semaglutide or tirzepatide better for weight loss vs. Semaglutide vs Tirzepatide: 2026 Comparison

Notably, Trulicity carries a higher risk of low blood sugar (hypoglycemia) when used with insulin or sulfonylureas (up to 20%), while Zepbound shows lower hypoglycemia rates (~5%)

Modern sulphonylureas and cardiovascular adverse effects: will CAROLINA put an end to the controversy

Description Retatrutide is a synthetic peptide designed for in vitro research applications involving GIP (glucose-dependent insulinotropic polypeptide), GLP-1 (glucagon-like peptide-1), and glucagon receptor pathways

To probe whether semaglutide exerts a direct adverse vascular effect, a separate randomized controlled trial specifically investigated its impact on retinal physiology